Hyperbaric Oxygen Therapy for Optic Neuropathies

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT06128720
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Hyperbaric Oxygen — DEVICE
    Participant will undergo 60 minutes of Hyperbaric oxygen at 1.5ATA while breathing 100% oxygen
  • Sham Hyperbaric Oxygen — DEVICE
    Participant will undergo 60 minutes of Sham Hyperbaric Oxygen at atmospheric pressure while breathing room air.

Study Details

The purpose of the study is to evaluate the neuroprotective efficacy of hyperbaric oxygen for the treatment in patients with optic neuropathy.

Key Dates

Start date
Nov 1, 2022
Status verified
May 2025
Primary completion
Jun 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Open Label
    Participants will get Hyperbaric oxygen therapy for 20 days to determine best methods for full trial.
  • Experimental: Active Hyperbaric Oxygen
    Participants will get Hyperbaric oxygen therapy for 20 days.
  • Placebo Comparator: Sham Hyperbaric Oxygen
    Participants will get a Sham Hyperbaric oxygen therapy for 20 days

Primary Outcome Measure

Change in Visual Field- Mean Deviation [ Time Frame: Baseline through 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Byers Eye InstitutePalo AltoCalifornia94303
Zac Wennberg-Smith
[email protected]
650-497-5942

Find similar trials in Palo Alto, CA

By condition
Glaucoma
By specialty
Ophthalmology
By research site
Byers Eye Institute· Palo Alto, CA

Related Studies